HeartBeam, Inc.(BEAT)

Medical - Specialties · Santa Clara, CA

$0.62-0.03 (-4.57%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T13:30:43.077Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:30:43.077Z.

Quote observation: 2026-10-06T13:30:04.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -20,302,000
Quote market capitalization: 34,652,918
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 8,722,000

FMP input reference: a5ea7848df566bb1fba137e14a23bd7a424b67da13a14cf2752e181034030ce3

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BEAT EBITDA Yield Metrics

EBITDA YIELD

N/A

BEAT Competitors' EBITDA Yield

BEAT

HeartBeam, Inc.

Current

Market Cap

$34.65M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELUT

Elutia Inc

vs BEAT

Market Cap

$35.68M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BCTX

BriaCell Therapeutics Corp.

vs BEAT

Market Cap

$36.54M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs BEAT

Market Cap

$36.79M

EBITDA Yield

N/A

TTM Avg

15.63%

3Y Avg

9.19%

5Y Avg

7.93%

ELTX

Elicio Therapeutics, Inc.

vs BEAT

Market Cap

$36.23M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BEAT

Market Cap

$36.26M

EBITDA Yield

N/A

TTM Avg

4.27%

3Y Avg

2.75%

5Y Avg

3.74%

EDSA

Edesa Biotech, Inc.

vs BEAT

Market Cap

$37.67M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

HBIO

Harvard Bioscience, Inc.

vs BEAT

Market Cap

$38.34M

EBITDA Yield

9.52%

TTM Avg

10.40%

3Y Avg

3.98%

5Y Avg

3.32%

IXHL

Incannex Healthcare Limited

vs BEAT

Market Cap

$38.41M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRCE

Grace Therapeutics, Inc.

vs BEAT

Market Cap

$33.52M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
HeartBeam, Inc. (BEAT)	$34.65M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$35.68M	N/A	N/A	N/A	N/A
BriaCell Therapeutics Corp. (BCTX)vs ›	$36.54M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$36.79M	N/A	15.63%	9.19%	7.93%
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.23M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$36.26M	N/A	4.27%	2.75%	3.74%
Edesa Biotech, Inc. (EDSA)vs ›	$37.67M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$38.34M	9.52%	10.40%	3.98%	3.32%
Incannex Healthcare Limited (IXHL)vs ›	$38.41M	N/A	N/A	N/A	N/A
Grace Therapeutics, Inc. (GRCE)vs ›	$33.52M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

BEAT EBITDA Yield Metrics

BEAT Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics